Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
- Published In:
- The lancet. Diabetes & endocrinology, 13(1), 15-28 (2025)
- Authors:
- Badve, Sunil V, Bilal, Anika, Lee, Matthew M Y, Sattar, Naveed, Gerstein, Hertzel C, Ruff, Christian T, McMurray, John J V, Rossing, Peter, Bakris, George, Mahaffey, Kenneth W, Mann, Johannes F E, Colhoun, Helen M, Tuttle, Katherine R, Pratley, Richard E, Perkovic, Vlado
- Database ID:
- RPEP-10049
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10049APA
Badve, Sunil V; Bilal, Anika; Lee, Matthew M Y; Sattar, Naveed; Gerstein, Hertzel C; Ruff, Christian T; McMurray, John J V; Rossing, Peter; Bakris, George; Mahaffey, Kenneth W; Mann, Johannes F E; Colhoun, Helen M; Tuttle, Katherine R; Pratley, Richard E; Perkovic, Vlado. (2025). Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.. The lancet. Diabetes & endocrinology, 13(1), 15-28. https://doi.org/10.1016/S2213-8587(24)00271-7
MLA
Badve, Sunil V, et al. "Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.." The lancet. Diabetes & endocrinology, 2025. https://doi.org/10.1016/S2213-8587(24)00271-7
RethinkPeptides
RethinkPeptides Research Database. "Effects of GLP-1 receptor agonists on kidney and cardiovascu..." RPEP-10049. Retrieved from https://rethinkpeptides.com/research/badve-2025-effects-of-glp1-receptor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.